ReachMD

Sanjiv S. Agarwala, MD, is Professor of Medicine, Temple University School of Medicine, Philadelphia, and Chief of Oncology and Hematology and Section Chief of Hematology/Oncology at St. Luke’s Cancer Center, St. Luke’s Health Network, Bethlehem, Pennsylvania. He is nationally and internationally recognized as an expert in the treatment of melanoma and is a pioneer in the development of new drugs for treating this disease. Dr. Agarwala has special interest and expertise in immunotherapy for cancer. Dr. Agarwala is board certified in Oncology, Hematology, and Internal Medicine. He is an active member of several professional and scientific societies, including the American Association for Cancer Research, the American Society of Clinical Oncology, and the European Society of Medical Oncology. Dr. Agarwala has authored or co-authored more than 150 publications, abstracts, and book chapters on melanoma and other cancers.